This reader by Foster
published by Ibis Reproductive Health
provides detailed information about three different regimens for
medication abortion and is also available in Arabic.
This article by Joffe and
Weitz, published in Social Science&
Medicine, describes the difficult approval process for Mifepristone and the
external challenges to its diffusion into medical practice that have been
created , touching upon the role of the pharmaceutical company, and the conflict between the FDA-approved and
an evidence-based regime among other issues.
This article published in The
Journal of the American Board of Family Medicine reports on a qualitative
study on women’s willingness to receive abortion care in a primary care
setting, noting the majority accepted the integration of abortion care into
family medicine settings.
This fact sheet developed forhe Abortion Access Project by Sacheen Carr-Ellis, MD, offers brief answers to some of the questions raised regarding the safety of mifepristone in response to the six reported death of women who had used the medication.
This article by Fiala and
Gemzell-Danielsson published in Contraception
looks at the incorporation of prostaglandin in the medication abortion regimen.
This article by Cohen et al published in Obstetrics & Gynecology examines
known four cases of infection after abortion in order to better understand the
risk for fatal toxic shocked caused by Clostridium sordellii.
This article by Winikoff et al published in Obstetrics and Gynecology compares the efficacy,
safety, and acceptability of oral immediately swallowed and buccal misoprostol in
combination with mifepristone, noting both as effective administration.
This article by Beal
published in the Journal of Midwifery
& Women’s Health discusses the implementation of medication abortion in
the work of advanced practice clinicians, looking at various topics such as
overview of the abortion issue, innovative protocols and other practical
issues.
